AEVIS VICTORIA SA header image

AEVIS VICTORIA SA

AEVS

Equity

ISIN CH0478634105 / Valor 47863410

SIX Swiss Exchange (2026-11-06)
CHF 14.30%

AEVIS VICTORIA SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

AEVIS VICTORIA SA is a Swiss investment company established in 2006 and publicly traded on the SIX Swiss Exchange. The company focuses its investment strategy on three primary sectors: healthcare, hospitality and lifestyle, and infrastructure, all of which are identified as having significant growth potential. AEVIS VICTORIA holds a substantial stake in Swiss Medical Network Holding SA, which is the only private hospital network operating across Switzerland's three main language regions. Additionally, the company has investments in MRH Switzerland AG, a luxury hotel group with properties in Switzerland and internationally, and Infracore SA, a real estate firm specializing in healthcare infrastructure. The company's portfolio also includes Swiss Hotel Properties AG, which manages hospitality real estate, and NESCENS SA, a brand focused on promoting better aging. Through these strategic investments, AEVIS VICTORIA aims to enhance value and capitalize on growth opportunities within its chosen sectors.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

10.0%1Y
-18.1%3Y
12.6%5Y

Performance

33.3%1Y
29.6%3Y
30.9%5Y

Volatility

Market cap

1474 M

Market cap (USD)

Daily traded volume (Shares)

3,981

Daily traded volume (Shares)

1 day high/low

14.3 / 13.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%INR 2,592.85
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.61%INR 5,265.20
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%USD 29.12
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 569.25
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%CHF 71.00
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%CHF 8.83
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%DKK 377.20